• Aspect Medical Systems (Norwood, Massachusetts) said that Boudewijn Bollen will retire from his role as president of international operations in 1Q08. After this, Bollen will serve on a part-time basis as a senior company advisor and will remain a member of the board of directors. Bill Floyd, VP of sales and marketing for Aspect, will work with Bollen throughout a transition period starting in Sept. 2007, and will be promoted to executive vice president of worldwide sales and marketing upon Bollen’s retirement. Aspect specializes in brain monitoring technology.

Scott Bruder, MD, was named senior VP and chief technology officer of BD (Becton, Dickinson and Company; Franklin Lakes, New Jersey), effective Sept. 1. Prior to joining BD, Bruder most recently was the worldwide VP for Johnson & Johnson Regenerative Therapeutics. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines.

• Cleveland Clinic (Cleveland, Ohio) reported the executive staff for its new healthcare venture, Sheikh Khalifa Medical City (SKMC) in Abu Dhabi. The team of Scott Strong, MD, Mila Henn, and Sulaiman Sulaiman will join Kenneth Ouriel, MD, who was CEO of SKMC last month. Strong, a colorectal surgeon at Cleveland Clinic’s main campus, will be chief medical officer; Henn will coordinate all operations and materials in Abu Dhabi as chief purchasing officer. Sulaiman will be chief information officer. Cleveland Clinic is a not-for-profit multispecialty academic medical center that integrates clinical and hospital care with research and education.

Susan Brownie was named CFO of Cogent Healthcare (Nashville, Tennessee). Previously Brownie directed finances at HealthStream. Cogent Healthcare provides comprehensive hospitalist programs to hospitals in 16 states.

Gary Seeger was named VP of quality assurance and regulatory affairs of Iridex (Mountain View, California). Previously, Seeger held the same position at Stellartech Research. Iridex makes therapeutic based laser systems.

Jim Talbot was named VP of quality and regulatory affairs of NeoGuide Systems (San Jose, California). Talbot most recently served as director of quality at Boston Scientific. NeoGuide Systems makes technology to prevent and treat colorectal cancer.

The Securities and Exchange Commission (Washington) said that Martin Dunn, deputy director of the division of corporation finance, will leave the agency at the end of August to join O’Melveny & Myers as a partner. Dunn served in many roles during his 19 years in the division of corporation finance, including chief counsel.

Charles Brooks was named VP of government affairs of SRA International (Fairfax, Virginia). Brooks most recently served as director of legislative affairs for the science & technology directorate within the department of homeland security. SRA International provides technology and consulting services to federal government organizations.